EMA accepts regulatory submission for Forxiga in adults with type 1 diabetes March 7, 2018 No Comments
EMA committee recommends change to marketing authorization terms for Feraccru Feb. 26, 2018 No Comments
BioCryst's Alpivab recommended for approval in E.U. for uncomplicated influenza Feb. 26, 2018 No Comments
RSS